Informationsbedarf Komplementärmedizin in der Onkologie

ZUSAMMENFASSUNG

Onkologisch tätige Ärzte und Ärztinnen vermeiden es häufig, mit ihren Patienten das Thema komplementäre Therapien anzuschneiden, da sie sich selbst nicht ausreichend informiert fühlen. Das kann sich ungünstig auf die langfristige Interaktion zwischen Arzt und onkologisch Erkranktem auswirken, der – so besagen es die Zahlen – höchstwahrscheinlich genau über diese Themen kompetent informiert werden möchte. Um diesem Bedürfnis nachzukommen, stellen sich dem Mediziner also drei Fragen: Woher bekomme ich verlässliche und fundierte Informationen, wie kommuniziere ich mein Wissen und gebe Empfehlungen und was möchte ich möglicherweise selbst an komplementärmedizinischen Therapien anbieten? In diesem Artikel werden die wichtigsten deutschsprachigen Informationsplattformen, Weiterbildungsprogramme für Onkologen und Ausbildungskurse diverser komplementärmedizinischer Therapien vorgestellt.

Abstract

Oncology physicians often avoid addressing the area of complementary treatment options with their patients because they themselves do not feel sufficiently informed. This can have an unfavorable effect on the long-term interaction between the physician and the oncological patient, who - according to the figures - most likely wants to be informed competently about precisely these topics. To meet this need, therefore, the physician faces three questions: where do I get reliable and sound information, how do I communicate my knowledge and make recommendations, and what complementary medicine therapies do I possibly want to offer myself? This article presents the most important German-language information platforms, continuing education programs for oncologists, and training courses of various complementary medicine therapies.

Schlüsselwörter

Krebs - Integrative Onkologie - Informationsbedarf Komplementärmedizin - Weiterbildung Komplementärmedizin

Key words

Cancer - integrative oncology - information requirements for complementary medicine - advanced training in complementary medicine

Publication History

Article published online:
24 June 2021

• Literatur

• 1 Zentrum für Krebsregisterdaten des RKI Im Internet https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Krebs_gesamt/krebs_gesamt_node.html Zugegriffen: 08.03.2021
• 2 Denieffe S, Gooney M. A meta-synthesis of women's symptoms experience and breast cancer. Eur J Cancer Care (Engl) 2011; 20: 424-435
• 3 Haidinger R, Bauerfeind I. Long-term side effects of adjuvant therapy in primary breast cancer patients: Results of a web-based survey. Breast Care (Basel) 2019; 14: 111-116
• 4 Fremd C, Hack CC, Schneeweiss A. et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet 2017; 295: 1239-1245
• 5 Keene MR, Heslop IM, Sabesan SS. et al. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract 2019; 35: 33-47
• 6 Grimm D, Mathes S, Woelber L. et al. Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany. Arch Gynecol Obstet. 2020: epub
• 7 Munstedt K, Vogt T, Rabanus ME. et al. Wishes and beliefs of cancer patients regarding counseling on integrative medicine. Breast Care (Basel) 2014; 9: 416-420
• 8 Corina G, Christine H, Klein G. Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis. Support Care Cancer 2016; 24: 3857-3862
• 9 Paepke D, Wiedeck C, Hapfelmeier A. et al. Prevalence and predictors for nonuse of complementary medicine among breast and gynecological cancer patients. Breast Care (Basel) 2020; 15: 380-385
• 10 Grimm D, Voiss P, Paepke D. et al. Gynecologists’ attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany. Arch Gynecol Obstet 2021; 303: 967-980
• 11 Koenig CJ, Ho EY, Trupin L. et al. An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits. Patient Educ Couns 2015; 98: 857-863
• 12 Samuels N, Ben-Arye E, Maimon Y. et al. Unmonitored use of herbal medicine by patients with breast cancer: reframing expectations. J Cancer Res Clin Oncol 2017; 143: 2267-2273
• 13 Klein E, Beckmann MW, Bader W. et al. Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey. Arch Gynecol Obstet 2017; 296: 295-301
• 14 Witt CM, Helmer SM, Schofield P. et al. Training oncology physicians to advise their patients on complementary and integrative medicine: An implementation study for a manual-guided consultation. Cancer 2020; 126: 3031-3041
• 15 Akpunar D, Bebis H, Yavan T. Use of complementary and alternative medicine in patients with gynecologic cancer: a systematic review. Asian Pac J Cancer Prev 2015; 16: 7847-7852
• 16 Drozdoff L, Klein E, Kiechle M. et al. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy. BMC Complement Altern Med 2018; 18: 259
• 17 Epstein RM, Street RL. The values and value of patient-centered care. Ann Fam Med 2011; 9: 100-103
• 18 Epstein RM. SR Jr. Patient-centered communication in cancer care: promoting healing and reducing suffering: National Cancer Institute. NIH Publication No. 07-6225. Bethesda, MD. 2007
• 19 Pincus HA, Patel SR. Barriers to the delivery of psychosocial care for cancer patients: bridging mind and body. J Clin Oncol 2009; 27: 661-662
• 20 Frenkel M, Ben-Arye E, Cohen L. Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 2010; 9: 177-185
• 21 Street RL, Slee C, Kalauokalani DK. et al. Improving physician-patient communication about cancer pain with a tailored education-coaching intervention. Patient Educ Couns 2010; 80: 42-47
• 22 Boywitt D. Methodische Grundlagen V1.1. IQTIG-Institut für Qualitätssicherung und Transparenz im Gesundheitswesen. Berlin. 2019
• 23 Cochrane Deutschland. Evidenzbasierte Medizin. Glossar Im Internet https://www.cochrane.de/de/cochrane-glossar#e
• 24 Witt CM, Balneaves LG, Carlson LE. et al. Education competencies for integrative oncology – results of a systematic review and an international and interprofessional consensus procedure. J Cancer Educ. 2020: epub
• 25 Witt CM, Bartsch HH, Güthlin C. et al. Kompetenznetz Komplementärmedizin in der Onkologie (KOKON) Ein wissenschaftlicher Beitrag zur Verbesserung der Versorgung. FORUM 2017; 32: 416-423
• 26 Klein GE, Guethlin C. Information and training needs regarding complementary and alternative medicine: A cross-sectional study of cancer care providers in Germany. Integr Cancer Ther 2018; 17: 380-387
• 27 Witt CM, Müller T. Komplementärmedizin in der gynäkologisch-onkologischen Sprechstunde: Wie mache ich mich fit dafür?. Gynäkologe 2021; 54: 32-37
• 28 AlOmeir O, Patel N, Donyai P. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory. Support Care Cancer 2020; 28: 5075-5084
• 29 Cardoso F, Paluch-Shimon S, Senkus E. et al. 5^th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol 2020; 31: 1623-1649
• 30 Fabi A, Bhargava R, Fatigoni S. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol 2020; 31: 713-723
• 31 Jordan B, Margulies A, Cardoso F. et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 2020; 31: 1306-1319
• 32 Greenlee H, DuPont-Reyes MJ, Balneaves LG. et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 2017; 67: 194-232